Visningssätt för begreppens/termernas förhållanden:
Det sätt begreppsrelationer visas:
Det sätt begreppsrelationer visas:
3-pyridinkarboxylsyra, 1,4-dihydro-2,6-dimetyl-5-nitro-4-(2-(trifluorm...
Hierarki: | ∟ ∟ ∟ ∟ ∟ 3-pyridinkarboxylsyra, 1,4-dihydro-2,6-dimetyl-5-nitro-4-(2-(trifluormetyl)fenyl)-,metylester 19 sidobegrepp∟ ∟ ∟ ∟ ∟ 3-pyridinkarboxylsyra, 1,4-dihydro-2,6-dimetyl-5-nitro-4-(2-(trifluormetyl)fenyl)-,metylester 19 sidobegrepp∟ ∟ ∟ ∟ 3-pyridinkarboxylsyra, 1,4-dihydro-2,6-dimetyl-5-nitro-4-(2-(trifluormetyl)fenyl)-,metylester 19 sidobegreppX |
Bredare villkor: | ∟ ∟ ∟ ∟ ∟ 3-pyridinkarboxylsyra, 1,4-dihydro-2,6-dimetyl-5-nitro-4-(2-(trifluormetyl)fenyl)-,metylester ∟ ∟ ∟ ∟ ∟ 3-pyridinkarboxylsyra, 1,4-dihydro-2,6-dimetyl-5-nitro-4-(2-(trifluormetyl)fenyl)-,metylester ∟ ∟ ∟ ∟ 3-pyridinkarboxylsyra, 1,4-dihydro-2,6-dimetyl-5-nitro-4-(2-(trifluormetyl)fenyl)-,metylester |
Anmärkning: | |
Anmärkning: | A dihydropyridine derivative, which, in contrast to NIFEDIPINE, functions as a calcium channel agonist. The compound facilitates Ca2+ influx through partially activated voltage-dependent Ca2+ channels, thereby causing vasoconstrictor and positive inotropic effects. It is used primarily as a research tool.
X |
Annotation: | a calcium channel agonist
X |
historyNote*: | 87
X |
publicMeSHNote*: | 87
X |
activeMeSHYear*: | 2007X |
dateCreated*: | 1986-06-02X |
dateEstablished*: | 1987-01-01X |
dateRevised*: | 2006-07-05X |
recordAuthorizer*: | sjnX |
recordMaintainer*: | agsX |
recordOriginator*: | RLSX |
Typ: | |
Samordna villkor: | |
URI: | |
Termer och motsvarande begrepp: | Bay-K-8644 (fi) X3-pyridinkarboxylsyra, 1,4-dihydro-2,6-dimetyl-5-nitro-4-(2-(trifluormetyl)fenyl)-,metylester (sv) Bay-K-8644 (sv, ersatt) 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester (en) BK-8644 (en, ersatt) Bay-K8644 (en, ersatt) Bay R5417 (en, ersatt) |
Dela: |
Laddar resultat...